Brand-new advancements in cancer diagnostics and treatment emerge each day! CTOAM stays up-to-date on all of the latest cancer research to make sure that you know what your best options are. Here’s what you need to know...

Hope for Stage IV Cancer Patients through Precision Oncology

Published by on April 18, 2018 5 Comments

Is precision oncology really that much better than conventional cancer care? The answer is, Yes! The survival rates for stage IV cancer are significantly better with CTOAM’s precision oncology process.  And here are the statistics to prove it.   In the following graph and tables, we outline the overall significant increase in survival rates for stage IV cancer that our patients experience in contrast to those seen with conventional/standard Canadian cancer care.  Live Longer with Precision Oncology The patients listed have had at least one or more of CTOAM’s recommended therapies. Additionally, the patient data used for this chart comes from clients who were all determined to be stage IV at the time they reached out to bring us on board. It is possible, if not probably,...
Read Article


Immunotherapy Cancer Treatment | How Immune Checkpoint Inhibitors Work

Published by on June 1, 2018 | Share your thoughts

One of the most promising new life-saving advancements in cancer care is Immunotherapy, which is a way to use your body’s own immune system to eliminate your cancer. Sound too good to be true? Read on to find out how it works! See how Immunotherapy has helped cancer patients like you: Colon cancer survivor Damian’s success story Melanoma survivor Joan’s success story What Is Immunotherapy for Cancer Treatment? The American Society of Clinical Oncology voted Immunotherapy as its top overall clinical advancement for both 2016 and 2017. So what, exactly, is it? Immunotherapy uses the body’s own immune system to treat cancer. The body’s immune system uses a “series checkpoints” to determine if cells are normal or a threat. Some forms of cancer bond with...
Read Article


8 Ways to Advocate for Your Cancer Care – This Could Save Your Life

Published by on June 1, 2018 2 Comments

Do you really need a cancer care advocate or is the basic care you receive from your public oncologist good enough? Read on to find out the truth about standard care and decide for yourself. Joan was 45 years old when she was diagnosed with stage IV metastatic melanoma. Her public oncologist gave her the option of standard chemotherapy, which, according to studies, would’ve given her approximately less than a year to live. Since her disease would not respond to standard treatments, her oncologist told her that there were no other treatment options. She was told to get her affairs in order. But Joan wasn’t ready to accept this – so she and her husband reached out to CTOAM. Our cancer experts helped them to access the...
Read Article


Squamous Cell Carcinoma | Julio’s Cancer-Free Success Story

Published by on May 22, 2018 | Share your thoughts

From Squamous Cell Carcinoma to Cancer-Free: Julio’s Success Story There is no greater reward than hearing from happy family members of patients we’ve helped. Here’s what the daughter of one of our patients shared with us when she updated CTOAM on her father’s health status. “My father is doing very well. He just had his appointment with his oncologist who gave him a glowing report. Best possible outcome. I am sure that the immunotherapy was instrumental in his cancer being undetectable a year after diagnosis…especially without surgery. We are confident that this good report will continue into the future. We are very grateful for your help and do believe more people should have access to this treatment [Keytruda]. We hope this will make the treatment...
Read Article


Renal Cell Carcinoma | New Targeted Treatment Discovery

Published by on May 22, 2018 | Share your thoughts

New cancer treatments are being discovered all the time, and recently a new one was found for renal cell carcinoma. Nearly 50 new targeted therapies are released every month, and approximately 500 new studies on cancer alone released each week. However, many of these new therapies can take years to become available through public health care in Canada, if at all, because of the the public healthcare system’s limitations with time and budget. Access the Newest Cancer Treatments Often, the only way to access these superior treatments is through a precision oncology service like CTOAM (Cancer Treatment Options and Management). Our precision oncology consultants use genetic testing to determine the mutations that are driving your cancer and match those to the newest targeted drugs available....
Read Article


Alternatives to Chemotherapy: Why It’s Highly Beneficial to Delay Palliative Chemo

Published by on May 11, 2018 | Share your thoughts

Are you looking for alternatives to chemotherapy? Targeted therapies allow cancer patients to avoid chemo and benefit from treatment that is more effective, and less invasive, than standard treatment – including chemo and radiation. A good example of this is the success story of Margaret, a CTOAM patient with breast cancer. Using a unique precision oncology process, CTOAM helped Margaret delay palliative chemotherapy for two years. During that time she went on targeted therapies and was able to benefit from a longer, and higher quality, life. In sharing Margaret’s story, many people have asked an important question. What’s So Great About Postponing Chemo for Two Years? CTOAM’s cancer expert, Alex Rolland, explains why delaying palliative chemo – and finding evidence-based alternatives to chemotherapy – is so important....
Read Article


Why Precision Oncology Works – Even if Some Reports on Targeted Therapies Say Otherwise

Published by on May 1, 2018 | Share your thoughts

Why You Should Trust Precision Oncology  Precision oncology and, more specifically, targeted therapies have been under attack since their inception. There’ve been numerous studies and reports claiming that targeted therapies have NOT lived up to expectations and are still inferior to standard therapies. However, a more detailed look at these so-called ineffective studies reveals many design flaws in their methodologies. When the data is presented accurately, precision oncology produces significant benefits in both overall survival and reduced side effects for cancer patients. Problem #1: Using Targeted Drugs Without the Required Biomarker One issue with many studies involving targeted therapies is the use of targeted therapies without prior testing to ensure the relevant biomarker is present in that patient’s tumour tissue. While this may seem like...
Read Article


Hope for Cancer Patients: Precision Oncology

Published by on April 25, 2018 | Share your thoughts

Precision Oncology Offers You More Time & Higher Quality of Life Precision Oncology offers evidence-based hope for cancer patients at any stage of their disease, including Stage IV cancers. CTOAM provides our patients with a unique Precision Oncology Process, which can be tailored according to the patient’s individual needs. You can see how we help patients like you in our success stories and patient interviews. This can involve everything from PET/CT scan to genetic testing to targeted therapy recommendations, advanced treatment monitoring, and personalized nutrition plans based on medical science. All of CTOAM’s recommendations are based on peer-reviewed medical research. We value facts over promises. Make Sure You Know ALL Your Cancer Treatment Options If you’re a cancer patient living in Canada, it’s likely that your oncologist...
Read Article


Can Exercise Prevent Cancer?

Published by on April 5, 2018 | Share your thoughts

Looking for a good reason to step up your exercise and weightlifting routine? Most of us know that exercise is beneficial for lowering stress and increasing energy. But rigorous exercise and weight training are also proven to help prevent cancer, as well as slowing the progression and metastasis of cancers. Read on to find out what they are – and then get yourself to the gym, stat! 4 Ways That Exercise Prevents Cancer Here are some of the main mechanisms behind how rigorous exercise inhibits cancers: 1. Reduced Angiogenesis Since cancer cells are rapidly reproducing, they need to recruit extra blood vessels to help with their high metabolism. When you exercise with weights, you limit the ability of tumours to hijack blood vessels. This is...
Read Article


New Treatment for Glioblastoma – How an Innovative Drug Combo is Saving Lives

Published by on April 5, 2018 | Share your thoughts

New research has found that the addition of tumour-treating fields to temozolomide maintenance improved progression-free survival (PFS) and overall survival (OS) in glioblastoma patients.   New Treatment for Glioblastoma: Addition of Tumour-Treating Fields to Maintenance Temozolomide in Glioblastoma Glioblastoma is one of the most difficult types of cancer to treat. However, treatments are continuing to improve as new precision oncology research emerges. About TTFields: Tumour-treating fields (TTFields) consist of low-intensity, alternating electric fields that are delivered by transducer arrays applied to the scalp. The tumour-treating fields modality interferes with glioblastoma cell division and organelle assembly by delivery of low-intensity alternating electric fields to the tumour. Therefore, researchers were interested in discovering whether adding TTFields to maintenance temozolomide chemotherapy would improve PFS and OS rates for...
Read Article